
Baseline Steroid Use Linked to Poorer Outcomes in ICI-Treated Lung Cancer
Baseline corticosteroid use was associated with worse outcomes and diminished biomarker reliability in patients with non–small cell lung cancer (NSCLC) treated with immunotherapy, according to a study published July 7 in Cancer Research Communications. The …